Ch 6: SECURITIES MARKET INTERMEDIARIES — V3: Challenger Twisted Scenarios & Dec 2026 Amendments
CS Executive
📚 Capital Market & Securities Laws
📖 Ch.6 — SECURITIES MARKET INTERMEDIARIES
⚖️ V3: Case Law & Landmark Precedents
⚡ Free Mode (Answers Locked)
⏱ Duration: 90 Mins
🎯 Total Marks: 50
Passed at: 20 Marks
Max Attempts: 10
⚖️ Statutory Applicability: Applicable for ICSI CS Executive Examinations (December 2026 Attempt - Syllabus 2022)
Exhaustive ICSI CS Executive Test Series with 4-Tier Rubrics, Statutory Analysis, and Real-world Corporate Problem Scenarios.
📑 Exam Questions
5 Questions • Total 50 MarksQuestion 1: Role, code of conduct, and SEBI registration requirements for Merchant Bankers.
10 Marks
📌 Incorporates SEBI (Merchant Bankers) Amendment Regulations, LODR Rumor Verification timelines (Regulation 30), and SAST indirect acquisition principles.
Sahyadri Ltd., an unlisted high-tech manufacturing company, plans to raise capital through an Initial Public Offering (IPO) of equity shares and simultaneously issue Zero Coupon Zero Principal (ZCZP) instruments through the Social Stock Exchange (SSE) for its CSR-aligned green initiative. Sahyadri appoints 'Kalinga Capital Advisors Pvt. Ltd.', a SEBI-registered Category-I Merchant Banker, as the lead manager. During the due diligence process, rumors float in the financial media regarding Sahyadri's potential acquisition of a distressed competitor, which Kalinga Capital fails to verify or act upon within the mandated timeline under Regulation 30(11) of SEBI (LODR) Regulations, 2015. Concurrently, an institutional investor attempting to acquire a 26% stake in Sahyadri utilizes an indirect creeping acquisition route, bypassing the open offer triggers under Regulation 3 of SEBI (SAST) Regulations, 2011, with the active connivance of Kalinga Capital's deal team. SEBI initiates an inspection under Section 15 of the SEBI Act, 1992, alleging failure of code of conduct, due diligence lapses, and abetment of market manipulation. Examine the registration requirements, statutory role, fiduciary code of conduct, and penal liabilities of Kalinga Capital under the SEBI Act, 1992, SEBI (Merchant Bankers) Regulations, 1992, SEBI (ICDR) Regulations, 2018, and SEBI (LODR) Regulations, 2015, supporting your arguments with relevant SAT/Supreme Court precedents and statutory timelines.
🔒 Official Model Solution
Model answers and self-evaluation solutions are available in the Premium Tier & Rankers Plan.
Question 2: Credit Rating Agencies (CRAs): Rating process, code of conduct, conflict of interest safeguards.
10 Marks
📌 Incorporates SEBI (CRA) Regulations amendments, LODR Regulation 30(11) rumor verification norms, and Social Stock Exchange ZCZP instrument disclosure standards.
A listed entity, Sahyadri Therapeutics Ltd., engaged in the issuance of Zero Coupon Zero Principal (ZCZP) instruments through the Social Stock Exchange (SSE), also floated a non-convertible debenture (NCD) issue rated by Kalinga Ratings Ltd., a SEBI-registered Credit Rating Agency (CRA). Kalinga Ratings Ltd. faced a severe conflict of interest as one of its independent rating committee members held a material beneficial interest in Sahyadri Therapeutics Ltd.’s subsidiary, and concurrent rumor verification under Regulation 30(11) of SEBI (LODR) Regulations, 2015 regarding a stalled rating trigger was pending. Concurrently, Kalinga Ratings failed to disclose the rating rationale within the statutory timelines, leading to a market panic. Examine the legal validity of the rating process, code of conduct violations, conflict of interest safeguards under SEBI (Credit Rating Agencies) Regulations, 1999, cross-statutory overlaps with SEBI (LODR) Regulations, 2015, relevant SAT/Supreme Court precedents, and penal consequences under the SEBI Act, 1992.
🔒 Official Model Solution
Model answers and self-evaluation solutions are available in the Premium Tier & Rankers Plan.
Question 3: Underwriters, Stock Brokers, and Registrar & Share Transfer Agents (RTA) statutory compliances.
10 Marks
📌 Incorporates SEBI Intermediaries (Amendment) Regulations, Social Stock Exchange ZCZP compliance norms, and stringent Cybersecurity & SDD guidelines.
A prominent SEBI-registered Stock Broker and Category-I Merchant Banker acting as a Lead Underwriter for an Initial Public Offering (IPO) of 'Sahyadri Green Tech Limited' (issuing ordinary equity and Zero Coupon Zero Principal (ZCZP) instruments on the Social Stock Exchange segment) faces complex statutory overlap liabilities. Concurrently, the Registrar & Share Transfer Agent (RTA) for Sahyadri is accused of massive data leakage and failure of robust cybersecurity audits, leading to severe unauthorized transfers of dematerialized securities. As the Chief Compliance Officer and Company Secretary, critically evaluate the statutory compliances, SEBI (Stock Brokers) Regulations, 1992, SEBI (Registrars to an Issue and Share Transfer Agents) Regulations, 1993, SEBI (Underwriters) Regulations, 1993, ICDR Regulations, 2018, and SEBI (LODR) Regulations, 2015. Detail the statutory liabilities, penal consequences under Section 15HA and 15HB of the SEBI Act, 1992, and outline an exhaustive Secretarial Action Plan incorporating December 2026 amendments.
🔒 Official Model Solution
Model answers and self-evaluation solutions are available in the Premium Tier & Rankers Plan.
Question 4: Comprehensive review of key exam provisions of SECURITIES MARKET INTERMEDIARIES (Part 4)
10 Marks
📌 Incorporates SEBI LODR rumor verification mandates, Chinese Wall compliance under Intermediary Regulations, ZCZP instruments on Social Stock Exchange, and SEBI Act penalty provisions.
Sahyadri Capital Advisors Private Limited, a registered Category-I Merchant Banker and portfolio manager, acts as the lead manager for an upcoming Initial Public Offering (IPO) of Kalinga Bio-Tech Ltd. Simultaneously, Sahyadri operates a proprietary research desk publishing equity research reports and running algorithmic execution models for institutional clients. During the pre-IPO quiet period, an unverified rumor circulates on social media platforms and financial blogs that Kalinga Bio-Tech has failed a key US FDA inspection for its primary manufacturing plant, threatening 45% of its projected export revenues. Under Regulation 30(11) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with recent amendments on mandatory rumor verification, Sahyadri's research desk issues a rapid advisory note corroborating the rumor based on 'independent channel checks,' leading to an immediate 20% crash in Kalinga Bio-Tech's pre-issue market sentiment. Concurrently, SEBI initiates an inspection into Sahyadri's Chinese Walls, alleging severe structural breaches between its merchant banking division and its research/broking desks under the SEBI (Merchant Bankers) Regulations, 1992, and the SEBI (Research Analysts) Regulations, 2014. Furthermore, SEBI discovers that Sahyadri has utilized funds from its Portfolio Management Services (PMS) discretionary clients to subscribe to Zero Coupon Zero Principal (ZCZP) instruments issued by a related Social Enterprise, bypassing client mandate limits and failing to maintain segregated demat accounts as mandated under the SEBI (Intermediaries) Regulations, 2008 and recent Social Stock Exchange frameworks. As the Chief Compliance Officer of Sahyadri, examine the legal validity of the rumor verification actions, the liability regarding Chinese Wall failures, the statutory penalties under Sections 15A, 15HB, and 15HA of the SEBI Act, 1992, and outline an exhaustive Secretarial Action Plan incorporating relevant SAT precedents and regulatory timelines.
🔒 Official Model Solution
Model answers and self-evaluation solutions are available in the Premium Tier & Rankers Plan.
Question 5: Comprehensive review of key exam provisions of SECURITIES MARKET INTERMEDIARIES (Part 5)
10 Marks
📌 Incorporates December 2026 statutory updates on Social Stock Exchange ZCZP instruments, LODR Regulation 30(11) mandatory rumor verification, and PIT SDD compliance for intermediaries.
Sahyadri Capital Advisors Private Limited, a registered Category-I Merchant Banker and portfolio manager, acts as the lead manager for a high-profile public issue of Zero Coupon Zero Principal (ZCZP) instruments on the Social Stock Exchange (SSE), while simultaneously managing discretionary portfolio management services (PMS) for institutional clients. In December 2026, SEBI conducts a special forensic inspection of Sahyadri Capital and reveals three critical operational anomalies: (i) Sahyadri allocated 45% of its discretionary PMS corpus into unlisted, illiquid non-convertible debentures of group entities without explicit prior written consent from clients, relying instead on a blanket omnibus authorization embedded in the ancient client agreement executed in 2021; (ii) During the pre-issue phase of the ZCZP instruments on the SSE, unverified media reports circulated regarding a massive regulatory probe against the anchor social enterprise, but Sahyadri failed to verify or clarify these circulating rumors within the mandatory timelines stipulated under Regulation 30(11) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SSE operational guidelines, contending that ZCZP issuers are exempt from LODR provisions; and (iii) Sahyadri's compliance officer failed to maintain structured digital database (SDD) logs under Regulation 3(5) of SEBI (Prohibition of Insider Trading) Regulations, 2015 for unpublished price-sensitive information (UPSI) shared with external ESG rating agencies during the due diligence window. Examine the legal validity of Sahyadri Capital's contentions and actions under the SEBI Act, 1992, SEBI (Portfolio Managers) Regulations, 2020, SEBI (LODR) Regulations, 2015, and SEBI (PIT) Regulations, 2015. Detail the penal consequences under Section 15HA and 15HB of the SEBI Act, 1992, citing relevant SAT and Supreme Court precedents.
🔒 Official Model Solution
Model answers and self-evaluation solutions are available in the Premium Tier & Rankers Plan.
Advertisement